Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Acute Exogenous Oral Ketone Supplementation on Immune Cells Function and Immune Cells Histone Β-hydroxybutyrylation

NCT06590623 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06590623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06590623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Acute Exogenous Oral Ketone Supplementation on Immune Cells Function and Immune Cells Histone Β-hydroxybutyrylation
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2024
Completion date
June 1, 2025
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

histone deacetylase (hdac) activity, immune functions, ketosis, metabolic